Skip to main content
Clinical Trials/NCT04574297
NCT04574297
Active, not recruiting
Not Applicable

The Impact of Genetic and Environmental Factors on the Progression of Chronic Pancreatitis:An Observational Study

Changhai Hospital0 sites798 target enrollmentJanuary 1, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pancreatitis
Sponsor
Changhai Hospital
Enrollment
798
Primary Endpoint
the Number of Patients Developing Pancreatic Insufficiency
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

To explore the impact on genetic and environmental factors for clinical manifestation, and the progression of chronic pancreatitis, including development of pancreatic insufficiency and other complications.

Detailed Description

The present study was an observational study aimed to explore the impact of genetic factors (rare pathogenic variants of CP) and environmental factors(smoking and alcohol assumption) on the clinical manifestation and progression of CP. The observation items included the pain patterns, incidence of complications of CP, pancreatic cancer and death.

Registry
clinicaltrials.gov
Start Date
January 1, 2011
End Date
December 31, 2030
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zhuan Liao

Principal Investigator

Changhai Hospital

Eligibility Criteria

Inclusion Criteria

  • patients with a diagnosis of chronic pancreatitis
  • agree to join the study and provide informed consent

Exclusion Criteria

  • autoimmune pancreatitis
  • pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis
  • the follow-up time less than 2 years
  • patients presenting with diabetes and/or steatorrhea at onset of CP.

Outcomes

Primary Outcomes

the Number of Patients Developing Pancreatic Insufficiency

Time Frame: 10 years

The primary endpoint was the number of patients developing pancreatic insufficiency, categorised as 1) diabetes and steatorrhea, 2) diabetes only, or 3) steatorrhea only.

Secondary Outcomes

  • Death(20 years)

Similar Trials